Policyholder Services

Will OMIC cover me for the intravitreal injection of kenalog?

Yes. Although the use of Kenalog has been FDA approved only for intramuscular administration, intra-articular administration, and administration within a tendon sheath, this steroid is routinely used on an off-label basis by ophthalmologists. Provided that the indication of the injection (whether subconjunctivally, subTenon, into the lid, or intravitreally) is appropriate and the physician is properly trained and experienced, OMIC will extend coverage for the insured’s use of Kenalog.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

#2. Leader in the industry.

A-rated by AM Best, OMIC is ranked #1 among 50 malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined and operating ratios, the two most relevant financial measurements for an insurance carrier.